Budget Impact Analysis Of Treatments For Hepatitis C Virus: What’s New?

Budget Impact Analysis And Long-Term Disease Implications Of Hepatitis C Treatments In Sweden.

Figure 4. Cost per cure for cirrhotic genotype 1 patients (by treatment regime) Hepatitis C Virus (HCV) is a global health problem with over 170 million people with a chronic HCV infection.1 Depending on the genetic differences, HCV is grouped into six genotypes with around half of the Swedish patients being infected with genotype 1. In Sweden the prevalence of chronic HCV is 0.36%, which corre...

New expensive treatments for hepatitis C infection.

New treatments for chronic hepatitis C

The current treatment of chronic hepatitis C since several years, the association of pegylated interferon and ribavirine, allows to obtain a virological eradication in 55% of patients, all genotypes and 45% of those infected with the genotype 1, the most prevalent. The cure, defined by an undetectable viremia 24 weeks after the discontinuation of treatment is associated to a improvement of the ...

Prevalence of Hepatitis B virus, Hepatitis C virus and human immunodeficiency virus infections among patients candidate for orthopedic trauma surgeries

Background: Infectious diseases are major public health problems, among which blood-borne ones are the most important infections. Patients who undergo orthopedic surgery are at higher risk of transmitting infectious diseases from and to others, due to repeated blood examinations and injection, drains secretion and receiving blood products. Accordingly, in this study we determined prevalence of ...

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection

BACKGROUND Boceprevir and telaprevir have recently showed dramatically better treatment outcomes than conventional PEGylated interferon plus ribavirin for the treatment of hepatitis C virus genotype 1, but the average cost per patient is unknown. METHODS In the UK context, we performed a budget impact analysis to estimate the average per patient cost of adding boceprevir or telaprevir to PEGy...